San Francisco Chronicle

Stocks give up an early lead and end lower

- By Ken Sweet, Damian J. Troise and Alex Veiga Ken Sweet, Damian J. Troise and Alex Veiga are Associated Press writers.

Stocks capped a day of muted trading on Wall Street with slight losses Tuesday, giving back some of their modest gains from a day earlier.

The S&P 500 slipped 0.1% after spending much of the day drifting between small gains and losses. Declines in banks, industrial companies and elsewhere pulled the market lower. Gains in some Big Tech companies, including Amazon and Facebook, helped keep the losses in check.

Smallcompa­ny stocks fell more than other areas of the market, while blue chip companies like Johnson & Johnson and General Electric climbed after reporting betterthan­expected results. Treasury yields rose.

The market has been mostly making small moves since last week, keeping the stock indexes near their recent record highs, as investors weigh solid corporate earnings results against renewed worries that troubles with COVID19 vaccine rollouts and the spread of new variants of coronaviru­s might delay a recovery from the pandemic.

“Most major indexes are hovering near alltime highs, so for the market to be taking a little breather is not too surprising, given the ascent we’ve seen recently,” said Angelo Kourkafas, investment strategist at Edward Jones.

The S&P 500 lost 5.74 points to 3,849.62. The benchmark index is within 0.2% of the record high it set Monday. The Dow Jones industrial average dropped 22.96 points, or 0.1%, to 30,937.04. The techheavy Nasdaq composite slid 9.93 points, or 0.1%, to 13,626.06. The Russell 2000 index of smaller companies gave up 13.42 points, or 0.6%, to 2,149.86.

Investors are in the midst of quarterly earnings reporting season for U.S. companies, and this is the busiest week so far. Dozens of large companies are reporting this week, from all parts of the economy, including American Express, J&J, Apple, GE and others.

More than 100 companies in the S&P 500 are scheduled to tell investors this week how they fared during the last three months of 2020. As a whole, analysts expect S&P 500 companies to say their fourthquar­ter profit fell 5% from a year earlier. That’s a milder drop than the 9.4% they were forecastin­g earlier this month, according to FactSet.

“The major theme, not only today but this week, is earnings season,” Kourkafas said. “The early results are encouragin­g.”

General Electric climbed 2.7% after the industrial conglomera­te reported a surge in cash flow. GE is attempting a turnaround after shedding unprofitab­le divisions and focusing more on big industrial products like jet engines and power equipment. Typically, when a company is in turnaround, investors care more about cash flow than quarterly profits because it shows the company is able to pay down debts.

Johnson & Johnson rose 2.7% after the company reported fourthquar­ter results that cruised past Wall Street’s expectatio­ns. A big jump in prescripti­on drug sales boosted the company’s revenue, but profits dove 57% due to higher research spending and onetime charges totaling $2.4 billion. The company also said it expects to share results from the latestage study of its experiment­al COVID19 vaccine, which requires only one dose, by early next week.

American Express fell 4.1% despite reporting strongerth­an expected earnings. The company’s card holders continue to postpone travel, entertainm­ent and dining out due to the pandemic, which has cut into its bottom line.

Shares in GEO Group and CoreCivic, which operate prisons, slumped following news that the Biden administra­tion will not be renewing federal government contracts with private prison operators. GEO Group slid 7.8%, while CoreCivic dropped 5.9%.

Meanwhile, traders are keeping a wary eye on rising coronaviru­s infections in various countries and a bumpy rollout of vaccinatio­ns in the U.S. The spread of variants that are thought to be more easily transmissi­ble and might be less effectivel­y targeted by existing vaccines is adding to alarm.

Vaccine maker Moderna said Monday that it will study whether a booster shot would be needed to protect against variants of the coronaviru­s, “out of an abundance of caution.”

President Biden has proposed a $1.9 trillion plan to send $1,400 to most Americans and deliver other support for the economy. But his party holds only the slimmest possible majority in the Senate, making approval uncertain. Several Republican­s have already voiced opposition to parts of the plan. On Tuesday, Senate Majority Leader Chuck Schumer said Democrats are prepared to push ahead with the relief package, even if it means using procedural tools to pass the legislatio­n without Republican­s.

The yield on the 10year Treasury edged higher to 1.04% from 1.02% late Monday.

Newspapers in English

Newspapers from United States